Immunotherapy of tumors: from the laboratory to the clinic
Castermans, A.; Vanwijck, R.
Revue Medicale de Liege 31(24): 767-768
1976
ISSN/ISBN: 0370-629X PMID: 1005982 Document Number: 101474
Document emailed within 1 workday
Related Documents
Tchekmedyian, N.; Gray, J.E.; Creelan, B.C.; Chiappori, A.A.; Beg, A.A.; Soliman, H.; Perez, B.A.; Antonia, S.J. 2015: Propelling Immunotherapy Combinations into the Clinic Oncology 29(12): 990-1002Helm, F. 1974: Immunotherapy of tumors Zeitschrift für Hautkrankheiten 49(17): 714-715
Tybor, K. 1992: Immunotherapy of brain tumors Neurologia i Neurochirurgia Polska 26(6): 861-866
Parmiani, G. 1994: Immunotherapy of tumors. Introduction Immunology Series 61: 227-230
Hermann, R. 1978: Immunotherapy of malignant tumors Deutsche Medizinische Wochenschrift 103(43): 1716
Kadagidze, Z.G. 1999: The immunodiagnosis and immunotherapy of tumors Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 5: 19-22
Bubeník, J. 1989: Perspectives in immunotherapy of malignant tumors Casopis Lekaru Ceskych 128(28): 865-867
Lindholm, L. 1989: Immunotherapy of tumors with monoclonal antibodies Acta Chirurgica Scandinavica. Supplementum 549: 46-49
Mickiewicz, E. 1996: Immunotherapy in melanoma and renal tumors Medicina 56(Suppl 1): 89-91
Gerdes, B.; Hassan, I.; Rothmund, M. 2006: Continuous training laboratory of a large surgical teaching clinic--the Marburg Surgical Training Laboratory "MaCh"! Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen Suppl: 308-309
Damianov, K.; Patrashkov, T.; Petkov, T.; Tonchev, T.; Petrov, P. 1990: Nonspecific immunotherapy with BCG vaccine in bladder tumors Khirurgiia 43(1): 48-53
Migliorini, D.; Dietrich, P.-Y. 2016: Immunotherapy for brain tumors: obstacles and perspectives Revue Medicale Suisse 12(516): 828-831
Okuno, K.; Sugiura, F.; Sukegawa, Y.; Inoue, K. 2012: New directions in immunotherapy for malignant solid tumors Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2075-2086
Lejeune, F.J. 1978: Is immunotherapy a weapon in the treatment of solid neoplastic tumors? Bruxelles Medical 58(8): 401-409
Blakeslee, J.R.; von Muenchhausen, W.; Cox, H.R. 1973: Tumor rejection and immunotherapy studies with simian virus 40-induced tumors Journal of Medicine 4(4): 233-247
Gouyon, B.; Ruszniewski, P. 1995: Chemoembolization, immunotherapy and hormone therapy of carcinoid and digestive neuroendocrine tumors Annales de Gastroenterologie et d'Hepatologie 31(2): 121-123
Semino, C.; Martini, L.; Queirolo, P.; Cangemi, G.; Costa, R.; Alloisio, A.; Ferlazzo, G.; Sertoli, M.R.; Reali, U.M.; Ratto, G.B.; Melioli, G. 1999: Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience Anticancer Research 19(6c): 5645-5649
Yamasaki, T.; Kikuchi, H. 1989: An experimental approach to specific adoptive immunotherapy for malignant brain tumors Nihon Geka Hokan. Archiv für Japanische Chirurgie 58(6): 485-492
Clavel, B. 1974: Medical treatment of malignant bone tumors (carcinolytics, hormonotherapy, immunotherapy) La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 50(4): 287-295
Rosen, T. 2007: The Propionibacterium acnes genome: from the laboratory to the clinic Journal of Drugs in Dermatology: Jdd 6(6): 582-586